搜索页_+Estrogen-receptor+positive+and+negative

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

常用资源

在“Elsevier电子期刊”中，命中：679条，耗时：0.0969854 秒

在所有数据库中总计命中：6,949条

1.Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index

作者：Makiko Ono¹ ; ² ; Hitoshi Tsuda³ ; ⁴ ; ^{htsuda@ndmc.ac.jp} ; Masayuki Yoshida⁴ ; Chikako Shimizu² ; Takayuki Kinoshita⁵ ; Kenji Tamura²

关键词：Cutoff ; Luminal subtype ; PR ; Prognostic factor ; Tumor size

刊名：Clinical Breast Cancer

出版年：2017

2.Cytologic assessment of estrogen receptor, progesterone receptor, and HER2 status in metastatic breast carcinoma

作者：Fresia Pareja ; MD ; PhD^a ; Melissa P. Murray ; DO^a ; Ryan Des Jean ; MD^b ; Fumiko Konno ; MD^a ; Maria Friedlander ; MPA ; CT (ASCP)^a ; Oscar Lin ; MD ; PhD^a ; Marcia Edelweiss ; MD^a ; ^{edelweim@mskcc.org}

关键词：Estrogen receptor ; Progesterone receptor ; HER2 ; Cytology ; FNA ; Metastasis ; Breast cancer

刊名：Journal of the American Society of Cytopathology

出版年：2017

3.Silver(I) complexes of methyl xanthate against human adenocarcinoma breast cancer cells

作者：Christina N. Banti^a ; ^{cbanti@cc.uoi.gr} ; Nikolaos Kourkoumelis^b ; Constantinos G. Tsiafoulis^c ; Stavroula Skoulika^d ; Sotiris K. Hadjikakou^a ; ^{shadjika@uoi.gr}

关键词：Bioinorganic chemistry ; Silver(I) complexes ; Xanthates ; Cytotoxic activity ; Structural activity relationship

刊名：Polyhedron

出版年：2017

4.An empirically derived dietary pattern associated with breast cancer risk is validated in a nested case-control cohort from a randomized primary prevention trial

作者：Brandon H. Hidaka^a ; Bruce F. Kimler^b ; Carol J. Fabian^c ; Susan E. Carlson^a ; ^{scarlson@kumc.edu}

关键词：Breast cancer risk ; Dietary pattern ; n-3 polyunsaturated fatty acids ; Tumor subtype ; Diet

刊名：Clinical Nutrition ESPEN

出版年：2017

5.Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS)

关键词：Breast cancer risk ; Estrogen-receptor positive and negative ; Sex steroid hormones

刊名：Steroids

出版年：2016

6.Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

作者：John W. Smith II¹ ; ^{john.smith@usoncology.com" class="auth_mail" title="E-mail the corresponding author} ; Svetislava Vukelja² ; Anthony D. Hoffman³ ; Vicky E. Jones⁴ ; Kristi McIntyre⁵ ; Erhan Berrak⁶ ; James X. Song⁶ ; Joyce O'Shaughnessy⁷

关键词：Adjuvant therapy ; Chemotherapy ; ER-positive ; Halaven ; HER2-negative

刊名：Clinical Breast Cancer

出版年：2016

7.Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison

作者：Nicole S. Spoelstra ; BS^a ; Diana M. Cittelly ; PhD^a ; Jessica L. Christenson ; PhD^a ; Michael A. Gordon ; PhD^a ; Anthony Elias ; MD^b ; Paul Jedlicka ; MD ; PhD^a ; Jennifer K. Richer ; PhD^a ; ^{Jennifer.Richer@ucdenver.edu" class="auth_mail" title="E-mail the corresponding author}

关键词：Dicer ; Breast cancer ; Estrogen receptor ; TNBC ; Immunohistochemistry

刊名：Human Pathology

出版年：2016

8.Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer

作者：Sheridan Wilson¹ ; Caroline Speers¹ ; Scott Tyldesley¹ ; Stephen Chia¹ ; Hagen Kennecke¹ ; Susan Ellard² ; Caroline Lohrisch¹ ; ^{clohrisch@bccancer.bc.ca" class="auth_mail" title="E-mail the corresponding author}

关键词：Adjuvant hormone therapy ; Five versus 10 years of therapy ; Good prognosis groups ; Hormone receptor-positive breast cancer ; Late recurrence risk

刊名：Clinical Breast Cancer

出版年：2016

9.Treatment strategies for advanced hormone receptor-positive and human epidermal growth factor 2-negative breast cancer: the role of treatment order

作者：Edith A. Perez ; ^{perez.edith@mayo.edu" class="auth_mail" title="E-mail the corresponding author}

关键词：Breast cancer ; Metastatic ; Hormone receptor ; Everolimus ; Endocrine therapy

刊名：Drug Resistance Updates

出版年：2016

10.Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer

作者：Chang Gong^a ; ¹ ; Weige Tan^a ; ² ; Kai Chen^a ; ³ ; Na You^b ; Shan Zhu^b ; Gehao Liang^a ; Xinhua Xie^c ; Qian Li^a ; Yunjie Zeng^d ; Nengtai Ouyang^d ; Zhihua Li^e ; Musheng Zeng^c ; ShiMei Zhuang^f ; Wan-Yee Lau^g ; ^h ; Qiang Liu^a ; Dong Yin^a ; Xueqin Wang^b ; Fengxi Su^a ; ^{fengxisu@vip.163.com" class="auth_mail" title="E-mail the corresponding author} ; Erwei Song^a ; ⁱ ; ^{songerwei02@aliyun.com" class="auth_mail" title="E-mail the corresponding author}

关键词：BCSCs ; Breast cancer stem cells ; miRNAs ; MicroRNAs ; DRFS ; Distant relapse free survival ; IHC ; Immunohistochemistry ; ER ; Estrogen receptor ; HR ; Hormone receptor ; CSCs ; Cancer stem cells ; RS ; Recurrence score ; FFPE ; Formalin-fixed paraffin-embedded ; SYSMH ; Sun Yat-sen Memorial Hospital ; IRB ; Institutional review board ; LASSO ; Least Absolute Shrinkage and Selection Operator ; ROC ; Receiver operating characteristic ; AUC ; Area under curve ; EMT ; Epithelial-mesenchymal transition ; PR ; Progesterone recep

刊名：EBioMedicine

出版年：2016

按检索点细分(679)

题名(38)

关键词(7)

文摘(602)

按出版年细分(679)

2027年及以后(31)

2017年(4)

2016年(57)

2015年(18)

2013年(57)

2012年(52)

2011年(50)

2010年(37)

2009年(26)

2008年(40)

2007年(25)

2006年(34)

2005年(33)

2004年(25)

2003年(20)

2002年(20)

2001年(22)

2000年(16)

2000年及以前(112)